News
-
-
-
-
-
-
PRESS RELEASE
Straumann Group reports strong growth in the second quarter and updates outlook due to selling DrSmile
Straumann Group reports strong growth in the second quarter, reaching CHF 1.3 billion in revenue with 16.1% organic growth. DrSmile to be sold to Impress Group while maintaining 20% holding. Updated outlook for 2024 shows double-digit revenue growth and profitability in the 27-28% range -
-
-
-
PRESS RELEASE
Straumann Group showed a solid start into 2024, with varied regional growth dynamic
Straumann Group reports strong organic revenue growth of 15.1% in the first quarter of 2024, reaching CHF 643.8 million. Regional dynamics vary, with Asia Pacific leading. New premium implant system and intraoral scanner launched